vs
Joby Aviation, Inc.(JOBY)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Joby Aviation, Inc.的1.2倍($35.5M vs $30.8M),Joby Aviation, Inc.同比增速更快(55965.5% vs 681.7%),RECURSION PHARMACEUTICALS, INC.自由现金流更多($-47.3M vs $-563.8M)
Joby Aviation是一家获风险投资支持的美国航空企业,专注研发电动垂直起降(eVTOL)飞行器,计划依托该产品推出空中出租车服务。公司总部位于加利福尼亚州圣克鲁斯,在加州圣卡洛斯、马里纳以及德国慕尼黑均设有办公地点。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
JOBY vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$30.8M
营收增速更快
JOBY
高出55283.7%
681.7%
自由现金流更多
RXRX
多$516.5M
$-563.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $30.8M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 55965.5% | 681.7% |
| 净利润同比 | 50.7% | 39.6% |
| 每股收益(稀释后) | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
JOBY
RXRX
| Q4 25 | $30.8M | $35.5M | ||
| Q3 25 | $22.6M | $5.2M | ||
| Q2 25 | — | $19.2M | ||
| Q1 25 | $0 | $14.7M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $26.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润
JOBY
RXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-401.2M | $-162.3M | ||
| Q2 25 | — | $-171.9M | ||
| Q1 25 | $-82.4M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | — | $-95.8M | ||
| Q2 24 | — | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率
JOBY
RXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率
JOBY
RXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | -804.8% | -3327.6% | ||
| Q2 25 | — | -916.8% | ||
| Q1 25 | — | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | — | -377.1% | ||
| Q2 24 | — | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率
JOBY
RXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -1777.4% | -3135.3% | ||
| Q2 25 | — | -894.2% | ||
| Q1 25 | — | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | — | -367.5% | ||
| Q2 24 | — | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益(稀释后)
JOBY
RXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.48 | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | $-0.11 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $1.4B | $1.1B |
| 总资产 | $1.8B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
JOBY
RXRX
| Q4 25 | $1.4B | $743.3M | ||
| Q3 25 | $978.1M | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | $812.5M | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务
JOBY
RXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益
JOBY
RXRX
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $896.5M | $1.0B | ||
| Q2 25 | — | $919.1M | ||
| Q1 25 | $859.4M | $933.9M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $524.6M | ||
| Q2 24 | — | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产
JOBY
RXRX
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $726.5M | ||
| Q2 24 | — | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比
JOBY
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-509.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-563.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | -1828.4% | -133.1% |
| 资本支出强度资本支出/营收 | 174.9% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-930.7M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
JOBY
RXRX
| Q4 25 | $-509.9M | $-46.1M | ||
| Q3 25 | $-139.2M | $-117.4M | ||
| Q2 25 | — | $-76.4M | ||
| Q1 25 | $-111.0M | $-132.0M | ||
| Q4 24 | — | $-115.4M | ||
| Q3 24 | — | $-59.2M | ||
| Q2 24 | — | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流
JOBY
RXRX
| Q4 25 | $-563.8M | $-47.3M | ||
| Q3 25 | $-152.2M | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | $-125.9M | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率
JOBY
RXRX
| Q4 25 | -1828.4% | -133.1% | ||
| Q3 25 | -674.3% | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度
JOBY
RXRX
| Q4 25 | 174.9% | 3.5% | ||
| Q3 25 | 57.7% | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图